BRISTOL MYERS SQUIBB CO (BMY) Business News Sept. 14, 2026, 12:20 UTC Clinical trial NCT06297226: primary completion date: 2027-06-30 → 2026-07-31. Full text
Register to leave comments News bot Sept. 14, 2026, 12:28 p.m. 📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical